Literature DB >> 21857291

Expanding the generation and use of economic and financial data to improve HIV program planning and efficiency: a global perspective.

Charles B Holmes1, Rifat Atun, Carlos Avila, John M Blandford.   

Abstract

Cost information is needed at multiple levels of health care systems to inform the public health response to HIV. To date, most attention has been paid to identifying the cost drivers of providing antiretroviral treatment, and these data have driven interventions that have been successful in reducing drug and human resource costs. The need for further cost information, especially for less well-studied areas such as HIV prevention, is particularly acute given global budget constraints and ongoing efforts to extract the greatest possible value from money spent on the response. Cost information can be collected from multiple perspectives and levels of the health care system (site, program, and national levels), and it is critical to choose the appropriate methodology in order to generate the appropriate information for decision-making. Organizations such as United States President's Emergency Plan for AIDS Relief, the Global Fund to Fight AIDS, Tuberculosis, and Malaria, and other organizations are working together to bridge the divide between the fields of economics and HIV program implementation by accelerating the collection of cost data and building further local demand and capacity for their use.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21857291     DOI: 10.1097/QAI.0b013e31821fa12d

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  5 in total

1.  HIV treatment produces economic returns through increased work and education, and warrants continued US support.

Authors:  Harsha Thirumurthy; Omar Galárraga; Bruce Larson; Sydney Rosen
Journal:  Health Aff (Millwood)       Date:  2012-07       Impact factor: 6.301

2.  Superior outcomes and lower outpatient costs with scale-up of antiretroviral therapy at the GHESKIO clinic in Port-au-Prince, Haiti.

Authors:  Cynthia Riviere; Elizabeth Faust; Thane Miller; Eduard J Beck; Elaine Baruwa; Patrice Severe; Karine Severe; Claudia Thomas Riché; Rachelle Cassagnol; Sidney Atwood; Morgan Esperance; Lauren Webster; Pierre Cremieux; Jean W Pape; Serena P Koenig
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-01       Impact factor: 3.731

3.  The determinants of HIV treatment costs in resource limited settings.

Authors:  Nicolas A Menzies; Andres A Berruti; John M Blandford
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

4.  Costs of providing food assistance to HIV/AIDS patients in Sofala province, Mozambique: a retrospective analysis.

Authors:  Mariana Posse; Rob Baltussen
Journal:  Cost Eff Resour Alloc       Date:  2013-08-28

5.  Quantifying and reducing statistical uncertainty in sample-based health program costing studies in low- and middle-income countries.

Authors:  Claudia L Rivera-Rodriguez; Stephen Resch; Sebastien Haneuse
Journal:  SAGE Open Med       Date:  2018-03-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.